Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 175,334 | 186,978 | 112,729 | 0 | N/A |
| TOTAL | $180,869 | $192,392 | $118,431 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 511 | 445 | 306 | N/A | N/A |
| Investments And Advances | 805 | 1,028 | 1,360 | 0 | 0 |
| TOTAL | $1,316 | $1,473 | $1,666 | $N/A | $N/A |
| Total Assets | $182,185 | $193,865 | $120,097 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 603 | 2,599 | 2,622 | 0 | 0 |
| Accrued Expenses | 5,948 | 4,745 | 4,786 | 0 | N/A |
| TOTAL | $6,551 | $7,344 | $7,408 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 32 | 35 | 27 | 0 | 0 |
| TOTAL | $32 | $35 | $27 | $N/A | $N/A |
| Total Liabilities | $6,583 | $7,379 | $7,435 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,131 | 32,130 | 32,130 | N/A | N/A |
| Common Shares | 3 | 3 | 536 | 0 | N/A |
| Retained earnings | -94,027 | -81,612 | -71,416 | 0 | N/A |
| Other shareholders' equity | 0 | 0 | 183,542 | 0 | 0 |
| TOTAL | $175,602 | $186,486 | $112,662 | $0 | $N/A |
| Total Liabilities And Equity | $182,185 | $193,865 | $120,097 | $0 | $0 |